Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title Technical note: Impact of dose voxel kernel (DVK) values on dosimetry estimates in 177 Lu and 90 Y radiopharmaceutical therapy (RPT) applications
Creator Danieli et al.
Author Rachele Danieli
Author Daniele Pistone
Author Jonathan Tranel
Author Francesca Botta
Author Carlos Uribe?Munoz
Author Davide Raspanti
Author Francesc Salvat
Author Scott J Wilderman
Author Manuel Bardiès
Author Ernesto Amato
Author Yuni K Dewaraja
Author Marta Cremonesi
Abstract Abstract Background Radiopharmaceutical therapy (RPT) is an increasingly adopted modality for treating cancer. There is evidence that the optimization of the treatment based on dosimetry can improve outcomes. However, standardization of the clinical dosimetry workflow still represents a major effort. Among the many sources of variability, the impact of using different Dose Voxel Kernels (DVKs) to generate absorbed dose (AD) maps by convolution with the time?integrated activity (TIA) distribution has not been systematically investigated. Purpose This study aims to compare DVKs and assess the differences in the ADs when convolving the same TIA map with different DVKs. Methods DVKs of 3 × 3 × 3 mm 3 sampling - nine for 177 Lu, nine for 90 Y - were selected from those most used in commercial/free software or presented in prior publications. For each voxel within a 11 × 11 × 11 matrix, the coefficient of variation (CoV) and the percentage difference between maximum and minimum values (% maximum difference) were calculated. The total absorbed dose per decay (SUM), calculated as the sum of all the voxel values in each kernel, was also compared. Publicly available quantitative SPECT images for two patients treated with 177 Lu?DOTATATE and PET images for two patients treated with 90 Y?microspheres were used, including organs at risk ( 177 Lu: kidneys; 90 Y: liver and healthy liver) and tumors' segmentations. For each patient, the mean AD to the volumes of interest (VOIs) was calculated using the different DVKs, the same TIA map and the same software tool for dose convolution, thereby focusing on the DVK impact. For each VOI, the % maximum difference of the mean AD between maximum and minimum values was computed. Results The CoV (% maximum difference) in voxels of normalized coordinates [0,0,0], [0,1,0], and [0,1,1] were 5%(21%), 9%(35%), and 10%(46%) for the 177 Lu DVKs. For the case of 90 Y, these values were 2%(9%), 4%(14%), and 4%(16%). The CoV (% maximum difference) for SUM was 9%(33%) for 177 Lu, and 4%(15%) for 90 Y. The variability of the mean tumor and organ AD was up to 19% and 15% in 177 Lu?DOTATATE and 90 Y?microspheres patients, respectively. Conclusions This study showed a considerable AD variability due exclusively to the use of different DVKs. A concerted effort by the scientific community would contribute to decrease these discrepancies, strengthening the consistency of AD calculation in RPT.
Publication Medical Physics
Pages mp.16729
Date 2023-09-15
Journal Abbr Medical Physics
Language en
DOI 10.1002/mp.16729
ISSN 0094-2405, 2473-4209
Short Title Technical note
URL https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.16729
Accessed 2023/11/23 - 12:07:49
Library Catalog DOI.org (Crossref)
Tags 177Lu, 90Y, dose-voxel-kernel, Humans, Liver, original, Radiometry, radionuclide therapy, Radiopharmaceuticals, Radiotherapy Planning, Computer-Assisted, Software
Date Added 2023/11/23 - 12:44:39
Date Modified 2024/12/15 - 11:18:40
Notes and Attachments PubMed entry (Attachment)
PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés